ARWR

41.3705.22%
DJ

Daniel J. Apel

Chief Financial Officer

Mr. Daniel J. Apel, also known as Dan, is Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. from May 13, 2025. Mr. Daniel J. Apel, also known as Dan, served as the Chief Financial Officer of Bayer Corporation since April 1, 2016. Mr. Apel serves as the Chief Financial Officer of Business Services LLC. Mr. Apel was at Walgreens Boots Alliance, where he served as Global Head of Financial Planning and Analysis from 2019 through 2024. Prior to joining Walgreens, Mr. Apel served in various significant roles in his career at Bayer, including as Chief Financial Officer for Bayer U.S. from 2016 through 2019 and as Chief Financial Officer for Bayer Canada and global Head of Accounting for the Bayer Healthcare Segment, based in Germany. Mr. Apel has served on the boards of the Biotechnology Innovation Organization (BIO) and Organization for International Investment, as well as a Trustee for the Health Institute of New Jersey. Mr. Apel served as Head of Business and Administration Partnering at Bayer Inc. until April 1, 2016. He serves as the Head of Business & Administration Partnering at Bayer Corporation and served as its Chief Financial Officer. He has been a Director of Conceptus, Inc., since June 2013. Mr. Apel earned his Master's degree in Business Administration from the University of California, Berkeley, a Bachelors of Arts Degree from the University of Pennsylvania and is a licensed Certified Public Accountant.

Positions